IHT Wealth Management LLC Boosts Stake in iShares Biotechnology ETF (NASDAQ:IBB)

IHT Wealth Management LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Get Rating) by 68.9% during the third quarter, Holdings Channel.com reports. The firm owned 5,011 shares of the financial services provider’s stock after purchasing an additional 2,044 shares during the period. IHT Wealth Management LLC’s holdings in iShares Biotechnology ETF were worth $586,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in IBB. Apollon Wealth Management LLC grew its stake in shares of iShares Biotechnology ETF by 0.8% in the third quarter. Apollon Wealth Management LLC now owns 10,445 shares of the financial services provider’s stock valued at $1,222,000 after buying an additional 83 shares in the last quarter. Hudock Inc. grew its stake in shares of iShares Biotechnology ETF by 0.9% in the third quarter. Hudock Inc. now owns 9,623 shares of the financial services provider’s stock valued at $1,125,000 after buying an additional 84 shares in the last quarter. Personal Capital Advisors Corp grew its stake in shares of iShares Biotechnology ETF by 3.2% in the third quarter. Personal Capital Advisors Corp now owns 2,877 shares of the financial services provider’s stock valued at $336,000 after buying an additional 88 shares in the last quarter. Patriot Financial Group Insurance Agency LLC grew its stake in iShares Biotechnology ETF by 1.5% during the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 5,868 shares of the financial services provider’s stock worth $686,000 after purchasing an additional 89 shares in the last quarter. Finally, NBT Bank N A NY grew its stake in iShares Biotechnology ETF by 0.3% during the 3rd quarter. NBT Bank N A NY now owns 35,942 shares of the financial services provider’s stock worth $4,204,000 after purchasing an additional 103 shares in the last quarter. Hedge funds and other institutional investors own 58.02% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB opened at $124.50 on Friday. iShares Biotechnology ETF has a 12 month low of $104.29 and a 12 month high of $138.74. The business has a fifty day moving average price of $131.94 and a 200 day moving average price of $128.93.

About iShares Biotechnology ETF

(Get Rating)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.